Home » Molecular Pathology in Drug Discovery and Development

Molecular Pathology in Drug Discovery and Development

€142.99
Title
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
applications
Category=MKF
Category=MKG
Category=PSD
contributions
cuttingedge
discipline
drug
editorial approach
eq_bestseller
eq_isMigrated=1
eq_nobargain
eq_non-fiction
eq_science
guide
leading
lights
molecular
molecular pathology
new tools
pathology
personalized
pharmaceutical
powerful
promises
reality
unmatched

Product details

  • ISBN 9780470145593
  • Weight: 680g
  • Dimensions: 155 x 236mm
  • Publication Date: 11 Sep 2009
  • Publisher: John Wiley & Sons Inc
  • Publication City/Country: US
  • Product Form: Hardback
Secure checkout Fast Shipping Easy returns
Description

Covers powerful new tools for drug development

Molecular pathology offers tools and techniques that can greatly enhance the drug discovery and development process, helping to make the promises of personalized medicine a reality. Molecular Pathology in Drug Discovery and Development provides an unmatched guide to this cutting-edge discipline and its applications to pharmaceutical science.

With contributions from leading lights in drug discovery, drug development, and molecular pathology balanced by a consistent editorial approach, this reference offers both an overview of molecular pathology and a close look at the methods as they are applied to the process of drug discovery and development. Presented as steps in the drug development process, the coverage includes the use of molecular pathology to:

  • Identify and validate new drug candidates

  • Enhance transcriptional profiling to better find and validate biomarkers

  • Assess toxicology

  • Employ toxicogenomics to identify genes relevant to the safety of compounds

  • Identify correct doses for different drugs

  • Identify patients for treatment

  • Develop molecular therapies

  • Further the new techniques of Immunohistochemistry and Immunofluorescence

With many tests and treatments already working today, drug research and development using molecular pathology has shown itself an extremely fruitful area. Molecular Pathology in Drug Discovery and Development gives practitioners an up-to-date resource on this highly active discipline and its role in furthering pharmaceutical research.
About

J. Suso Platero is Director of Oncology Biomarkers at Centocor. Formerly, he was associate director of molecular pathology at Bristol-Myers Squibb. Dr. Platero has more than ten years of experience in the discovery, development, and validation of assays for clinical purposes.